Targeting sigma receptors: novel medication development for drug abuse and addiction
about
The cross-talk of HIV-1 Tat and methamphetamine in HIV-associated neurocognitive disordersBehavioral, biological, and chemical perspectives on atypical agents targeting the dopamine transporterStimulants as specific inducers of dopamine-independent σ agonist self-administration in ratsSigma receptor agonists: receptor binding and effects on mesolimbic dopamine neurotransmission assessed by microdialysis.N-substituted benztropine analogs: selective dopamine transporter ligands with a fast onset of action and minimal cocaine-like behavioral effectsSLC6 transporters: structure, function, regulation, disease association and therapeuticsSynthesis and in vitro biological evaluation of carbonyl group-containing analogues for σ1 receptors.Synthesis and pharmacological evaluation of 6-acetyl-3-(4-(4-(4-fluorophenyl)piperazin-1-yl)butyl)benzo[d]oxazol-2(3H)-one (SN79), a cocaine antagonist, in rodentsA Role for Sigma Receptors in Stimulant Self Administration and Addiction.Decreases in cocaine self-administration with dual inhibition of the dopamine transporter and σ receptors.Self-administration of cocaine induces dopamine-independent self-administration of sigma agonists.Synthesis and σ1 Receptor Binding of Halogenated N,N'-Diphenethylethylenediamines.Tetrahydroprotoberberine alkaloids with dopamine and σ receptor affinity.Effects of the selective sigma receptor ligand, 1-(2-phenethyl)piperidine oxalate (AC927), on the behavioral and toxic effects of cocaineSigma receptors [σRs]: biology in normal and diseased statesCM156, a sigma receptor ligand, reverses cocaine-induced place conditioning and transcriptional responses in the brain.Sigma-1 receptor chaperones regulate the secretion of brain-derived neurotrophic factor.Pharmacological characterization of a dopamine transporter ligand that functions as a cocaine antagonist.Sigma-1 Receptor Antagonists: A New Class of Neuromodulatory Analgesics.Loss of Sigma-1 Receptor Chaperone Promotes Astrocytosis and Enhances the Nrf2 Antioxidant Defense.Mechanisms of activation of nucleus accumbens neurons by cocaine via sigma-1 receptor-inositol 1,4,5-trisphosphate-transient receptor potential canonical channel pathways.Are sigma receptor modulators a weapon against multiple sclerosis disease?
P2860
Q26777952-D28D2B3C-EE5E-47AE-BE5D-C3B708589329Q26829749-57BA2933-1DD7-48EE-B2DC-04FD8BB9E463Q30546325-3F248234-C92A-4DC4-BD46-B349E79E5A3DQ34462194-F060B1DC-C37D-47B3-9F4C-B6799F64ECC1Q34552126-D153208A-249F-434D-AD12-394A8DE73524Q34649517-D93B5642-CEED-4A63-821F-A0B1B8851E8FQ35148443-4785FCCE-C6B1-46DC-A5C8-B1FD208E84C3Q35176885-23950A1B-9619-47A3-BE28-CDB9EB126711Q35197016-80C3C445-5370-48BE-9505-A96EA4105BC1Q35429841-FE567C86-0902-44B7-BEB6-83B888DF3BFCQ36610032-7D860F07-E2D3-41F1-895E-6F740CF89980Q36737209-4CBC3138-C58A-4954-87F5-119C28167A14Q36803270-7AF25D25-0689-4731-8A5B-7EA9C4698A48Q36870910-CCA6B9E0-0F74-4AF2-B824-1AB7368B6C01Q37000551-59D76462-77A6-4FF5-A4CC-10321E097E42Q37052590-F0C1418E-9C65-4C0D-A46A-4283BF046A77Q37300447-219AC990-F2DF-4C4E-8917-37DCE1C9A2DAQ37405350-2CBC7679-F7F7-4E3F-A60D-D15B97FBA11FQ39158236-54272923-D96D-495B-8BC2-078B7B736B94Q41532363-053FF1BD-0DAA-41A8-859E-7425B2EE20DAQ41539028-FA8491CD-DE4F-46AF-8E13-CC303814E357Q47596098-04979BB2-7297-4531-8AD3-586D92DB5090
P2860
Targeting sigma receptors: novel medication development for drug abuse and addiction
description
2009 nî lūn-bûn
@nan
2009 թուականի Յուլիսին հրատարակուած գիտական յօդուած
@hyw
2009 թվականի հուլիսին հրատարակված գիտական հոդված
@hy
2009年の論文
@ja
2009年学术文章
@wuu
2009年学术文章
@zh-cn
2009年学术文章
@zh-hans
2009年学术文章
@zh-my
2009年学术文章
@zh-sg
2009年學術文章
@yue
name
Targeting sigma receptors: novel medication development for drug abuse and addiction
@ast
Targeting sigma receptors: novel medication development for drug abuse and addiction
@en
Targeting sigma receptors: novel medication development for drug abuse and addiction
@nl
type
label
Targeting sigma receptors: novel medication development for drug abuse and addiction
@ast
Targeting sigma receptors: novel medication development for drug abuse and addiction
@en
Targeting sigma receptors: novel medication development for drug abuse and addiction
@nl
prefLabel
Targeting sigma receptors: novel medication development for drug abuse and addiction
@ast
Targeting sigma receptors: novel medication development for drug abuse and addiction
@en
Targeting sigma receptors: novel medication development for drug abuse and addiction
@nl
P2860
P356
P1476
Targeting sigma receptors: novel medication development for drug abuse and addiction
@en
P2093
Rae R Matsumoto
P2860
P356
10.1586/ECP.09.18
P407
P577
2009-07-01T00:00:00Z